Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Cancers|April 23, 2022
Medullary Thyroid Carcinoma Mutational Spectrum Update and Signaling-Type Inference by Transcriptional Profiles: Literature Meta-Analysis and Study of Tumor SamplesEmanuela Minna, Paola Romeo, Matteo Dugo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcomaElena Tamborini, Lorena Bonadiman, Angela Greco, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 12, 2008
Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinomaCristina Ferrario, Paola Lavagni, Manuela Gariboldi, et al.
Plos One|September 30, 2010
Integrated ligand-receptor bioinformatic and in vitro functional analysis identifies active TGFA/EGFR signaling loop in papillary thyroid carcinomasDebora Degl'Innocenti, Chiara Alberti, Giancarlo Castellano, et al.
Journal of the National Cancer Institute|January 30, 2009
T670X KIT mutations in gastrointestinal stromal tumors: making sense of missenseTiziana Negri, Giovanni Maria Pavan, Emanuela Virdis, et al.
Biochemical Pharmacology|June 27, 2009
Concomitant downregulation of proliferation/survival pathways dependent on FGF-R3, JAK2 and BCMA in human multiple myeloma cells by multi-kinase targetingGiuliana Cassinelli, Domenica Ronchetti, Diletta Laccabue, et al.
International Journal of Clinical Practice|October 20, 2018
A multi-level strategy for a long lasting reduction in unnecessary laboratory testing: A multicenter before and after study in a teaching hospital networkYannick Erard, Rosaria Del Giorno, Anna Zasa, et al.
Swiss Medical Weekly|November 7, 2024
Antipsychotic, benzodiazepine and Z-drug prescriptions in a Swiss hospital network in the Choosing Wisely and COVID-19 eras: a longitudinal studyVanessa Gagliano, Gloria Salemme, Alessandro Ceschi, et al.
Oncotarget|October 1, 2014
Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involvedMaria Grazia Vizioli, Joana Santos, Silvana Pilotti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigenLuisa Novellino, Nicolina Renkvist, Francesca Rini, et al.
Pageof 8